Skip to content

Effects of Osteopathic Manipulative Treatment and Bio Electro-Magnetic Regulation Therapy on Neck Pain in Adults

Effects of Osteopathic Manipulative Treatment (OMT) and Bio Electro-Magnetic Regulation (BEMER) Therapy on Neck Pain in Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05889039
Enrollment
44
Registered
2023-06-05
Start date
2019-09-17
Completion date
2022-02-16
Last updated
2023-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain

Keywords

Neck Pain, Osteopathic Manipulative Treatment (OMT), BEMER

Brief summary

Neck pain is a common ailment in the United States. Although there are several different treatments and approaches to help individuals with neck pain, the number affected by this condition has been steadily increasing. OMT has been shown to be helpful in the treatment of neck pain. In fact, the use of OMT has been shown to increase mobility of the myofascial tissues, visceral motion and decrease pain in patients with neck pain. Bio Electro-Magnetic Regulation (BEMER) Therapy is a therapeutic modality that deploys a biorhythmically defined stimulus through a Pulsed Electromagnetic Field (PEMF), which leads to an increase in blood flow. The positive effects of BEMER on the circulation has been shown to result in significant increases in arteriovenous oxygen difference, number of open capillaries, arteriolar and venular flow volume, and flow rate of red blood cells in the microvasculature. Therefore, BEMER can potentially be used in the treatment of neck pain by improving microcirculation in muscular tissue. Therefore, it is possible that the combination of OMT and BEMER therapy may provide additive effects in reducing neck pain. The purpose of this study is to investigate the individual and combined effects of OMT and BEMER therapy on neck pain in adults.

Detailed description

Neck Pain is defined as pain in the neck with or without pain referred to one or both upper limbs that lasts for at least one day. It has been estimated that 66% of the population will suffer from neck pain at some point during their lifetime and has been reported as the fourth leading cause of disability worldwide. There is considerable variation in the reported prevalence rates of neck pain, most likely because of differences in the definition of neck pain and the lack of homogeneity in the studies. Current available studies suggest the one-year estimated incidence of neck pain to range between 10.4% and 21.3%, with a higher incidence noted in computer and office workers. The prevalence of neck pain ranges from 10% to 20%, and the most common cause of neck pain in adults stems from degenerative changes in the cervical spine. Most cases of neck pain tend to run an episodic course over one's lifetime, thus relapses are relatively common. The differential diagnosis for neck pain is extensive, and a methodical approach is essential to rule out potentially life-threatening conditions. The vast majority of neck pain is not due to organic pathology, and thus, has been termed non-specific or mechanical. Interventions available to manage neck pain include analgesics, physiotherapy, educational modalities, exercise, and manual therapy. While useful in acute, short-term reduction of pain, analgesic therapy such as NSAIDs (nonsteroidal anti-inflammatory drugs) produce significant side effects of gastrointestinal bleeding and cardiovascular events. Use of opioids, while also useful for acute, short-term pain relief, should produce hesitation in prescription due to risk of opioid dependence and hyperalgesia syndromes. Osteopathic manipulative treatment (OMT) is a fundamental skill set that osteopathic physicians acquire early during their medical training and is widely utilized among practicing osteopathic physicians to treat neck pain and other musculoskeletal complaints. OMT is a unique, hands-on treatment modality used by osteopathic physicians to augment the conventional management of neck pain and has been studied to demonstrate favorable outcomes in the treatment of neck pain. In addition to conventional treatment modalities, Bio-Electro-Magnetic Energy Regulation (BEMER) therapy (BEMER International AG) has emerged as a proposed therapeutic option. BEMER therapy utilizes a biorhythmically defined stimulus through a pulsed electromagnetic field. BEMER devices operate with unique parameters and are postulated to have a primary effect of improving tissue microcirculation. BEMER therapy leads to an increase in the number of open capillaries, vasomotion of micro vessels, arteriovenous oxygen difference, arteriolar and venular flow volume, and flow rate of red blood cells in a specific microcirculatory area. Multiple studies have demonstrated positive results in musculoskeletal pain management with the utilization of BEMER therapy. One study in particular demonstrated a potential additive, subjective decrease in reported back pain and improved functional ability after treatment with both OMT and BEMER therapy. The musculoskeletal, lymphatic, and fascial concepts of OMT have long been comprehensively and collectively proposed as the mechanisms by which the therapy provides alleviation of common musculoskeletal ailments. Existing literature suggests benefit from OMT, however, the need for further exploration of manual therapy remains. As previously discussed, BEMER therapy can reduce musculoskeletal pain via enhanced microcirculation. Therefore, it is plausible that the combination of OMT and BEMER therapy may potentially enhance circulation to the vascular beds in myofascial tissue and could substantially reduce neck pain. The objective of this study was to assess the individual and combined effects of OMT and BEMER therapy in patients with non-specific neck pain.

Interventions

DEVICEBEMER

Bio-Electro-Magnetic Energy Regulation (BEMER) is an emerging therapeutic modality that deploys a biorhythmically defined stimulus through a pulsed electromagnetic field and has been shown to reduce musculoskeletal pain.

PROCEDUREOMT

Osteopathic manipulative therapy (OMT) is a form of manual therapy utilized by osteopathic physicians and some allopathic physicians to treat a broad variety of musculoskeletal ailments, including neck pain.

PROCEDURESham OMT + Sham BEMER

Participants in the CONTROL group received light touch and BEMER sham treatments. Researchers placed their hands lightly on the subject's cervical paraspinal muscles in the supine position and on the upper thoracic paraspinal muscles in the prone position for approximately 5 minutes. This was done to mimic myofascial release techniques; however, no pressure or action was done. In addition, the subject's laid supine on the BEMER mat (as they would do during a BEMER session), but the device was not activated.

Sponsors

Lake Erie College of Osteopathic Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* LECOM-Bradenton faculty, staff and Students currently enrolled in LECOM- Bradenton's osteopathic medical program, pharmacy program, dental program, and master's program who are currently experiencing neck pain for at least two weeks will be approached for recruitment.

Exclusion criteria

* Subjects will be excluded if they have previously participated in the study, are unable to provide informed consent, are currently pregnant, or have a known medical history of any of the following: 1. Psychiatric conditions 2. Skin disorders or open wounds precluding skin contact 3. Fasciitis or fascial tears 4. Myositis 5. Neurological symptoms such as numbness, tingling, weakness in upper extremities 6. Neoplasia 7. Bone fracture, osteomyelitis, or osteoporosis 8. Coagulation problem 9. Deep vein thrombosis 10. Adrenal diseases/syndromes 11. Acute upper or lower respiratory infection 12. Immunosuppressive syndromes 13. Radiation or chemotherapy within the past 3 years 14. Lupus 15. Osteopenia 16. Congestive heart failure 17. BMI greater than 30 18. Any other autoimmune disease not stated above 19. Medication changes within the last 4 weeks 20. Asthma exacerbations within the last 4 weeks 21. Immunosuppressive therapy as a consequence of organ transplantation 22. Immunosuppressive therapy as a consequence of allogeneic cellular transplantations or bone marrow stem cell transplantation 23. Other conditions often requiring immunosuppressive therapy 24. Anticoagulant therapy 25. Known sensitivity to the carotid sinus reflex 26. Advanced carotid disease 27. Down syndrome

Design outcomes

Primary

MeasureTime frameDescription
Neck Pain Rating Neck Disability Index (NDI)Within 1 week of completion of 3-week intervention periodAssessed by questionnaire rating, compared with pre-intervention rating Neck Disability Index (NDI). Score ranges 0-50. Minimum score=0 (no activity limitation), Maximum score=50 (complete activity limitation). Lower scores is better as it reflect lower activity limitation
Neck Pain Rating Visual Analog Scale (VAS)Within 1 week of completion of 3-week intervention periodAssessed by questionnaire rating, compared with pre-intervention rating Visual Analog Scale (VAS). Score ranges 0-100. Minimum score=0 (no pain), Maximum score=100 (worst pain ever felt). Lower scores is better as it reflect lower pain
Quality of Life Rating Short Form 12-item (SF-12) Health SurveyWithin 1 week of completion of 3-week intervention periodAssessed by questionnaire rating, compared with pre-intervention rating Short form 12-item (SF-12) health survey. Scores range 0%-100%. Score of 0 (minimum) no pain. Score of 100 (maximum) lot of pain. Lower scores is better as it reflect lower pain

Countries

United States

Participant flow

Participants by arm

ArmCount
OMT + BEMER PLACEBO
Participants in the CONTROL group received light touch and BEMER sham treatments. Researchers placed their hands lightly on the subject's cervical paraspinal muscles in the supine position and on the upper thoracic paraspinal muscles in the prone position for approximately 5 minutes. This was done to mimic myofascial release techniques; however, no pressure or action was done. In addition, the subject's laid supine on the BEMER mat (as they would do during a BEMER session), but the device was not activated. Sham OMT + Sham BEMER: Participants in the CONTROL group received light touch and BEMER sham treatments. Researchers placed their hands lightly on the subject's cervical paraspinal muscles in the supine position and on the upper thoracic paraspinal muscles in the prone position for approximately 5 minutes. This was done to mimic myofascial release techniques; however, no pressure or action was done. In addition, the subject's laid supine on the BEMER mat (as they would do during a BEMER session), but the device was not activated.
12
Experimental: Bio Electro-Magnetic Regulation (BEMER) Therapy
Participants receiving BEMER therapy laid supine on the BEMER mat (BEMER International AG). The BEMER was set at intensity 3 for week 1, intensity 4 for week 2, and intensity 5 for week 3. The B.Pad (BEMER International AG) was placed under their cervical region. B.Pad® settings were set at Program 1 (8 minutes long) in week 1 through week 3. These settings were selected based on the manufacturer's recommendations. BEMER: Bio-Electro-Magnetic Energy Regulation (BEMER) is an emerging therapeutic modality that deploys a biorhythmically defined stimulus through a pulsed electromagnetic field and has been shown to reduce musculoskeletal pain.
12
OMT (Osteopathic Manipulative Treatment)
Participants receiving OMT were treated with a standardized sequence to the areas where somatic dysfunctions were found. OMT: Osteopathic manipulative therapy (OMT) is a form of manual therapy utilized by osteopathic physicians and some allopathic physicians to treat a broad variety of musculoskeletal ailments, including neck pain.
10
OMT+BEMER
Participants receiving BEMER therapy laid supine on the BEMER mat (BEMER International AG). The BEMER was set at intensity 3 for week 1, intensity 4 for week 2, and intensity 5 for week 3. The B.Pad (BEMER International AG) was placed under their cervical region. B.Pad® settings were set at Program 1 (8 minutes long) in week 1 through week 3. These settings were selected based on the manufacturer's recommendations. OMT was performed prior to BEMER therapy for those in the combined group. Participants were treated with a standardized sequence to the areas where somatic dysfunctions were found. BEMER: Bio-Electro-Magnetic Energy Regulation (BEMER) is an emerging therapeutic modality that deploys a biorhythmically defined stimulus through a pulsed electromagnetic field and has been shown to reduce musculoskeletal pain. OMT: Osteopathic manipulative therapy (OMT) is a form of manual therapy utilized by osteopathic physicians and some allopathic physicians to treat a broad variety of musculoskeletal ailments, including neck pain.
10
Total44

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall Studyerror in completing survey0200
Overall StudyLost to Follow-up4000

Baseline characteristics

CharacteristicTotalOMT + BEMER PLACEBOExperimental: Bio Electro-Magnetic Regulation (BEMER) TherapyOMT (Osteopathic Manipulative Treatment)OMT+BEMER
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
44 Participants12 Participants12 Participants10 Participants10 Participants
Age, Continuous25.2 years
STANDARD_DEVIATION 1.8
25.3 years
STANDARD_DEVIATION 1.6
24.6 years
STANDARD_DEVIATION 1.6
25.9 years
STANDARD_DEVIATION 2.5
24.8 years
STANDARD_DEVIATION 1.8
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
44 Participants12 Participants12 Participants10 Participants10 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants0 Participants0 Participants
Region of Enrollment
United States
44 participants12 participants12 participants10 participants10 participants
Sex: Female, Male
Female
32 Participants8 Participants9 Participants7 Participants8 Participants
Sex: Female, Male
Male
12 Participants4 Participants3 Participants3 Participants2 Participants
Visual Analog Scale20.7 units on a scale
STANDARD_DEVIATION 20.4
20.3 units on a scale
STANDARD_DEVIATION 20.2
13.2 units on a scale
STANDARD_DEVIATION 14
16.5 units on a scale
STANDARD_DEVIATION 13.8
32.9 units on a scale
STANDARD_DEVIATION 33.4

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 120 / 100 / 10
other
Total, other adverse events
0 / 120 / 120 / 100 / 10
serious
Total, serious adverse events
0 / 120 / 120 / 100 / 10

Outcome results

Primary

Neck Pain Rating Neck Disability Index (NDI)

Assessed by questionnaire rating, compared with pre-intervention rating Neck Disability Index (NDI). Score ranges 0-50. Minimum score=0 (no activity limitation), Maximum score=50 (complete activity limitation). Lower scores is better as it reflect lower activity limitation

Time frame: Within 1 week of completion of 3-week intervention period

ArmMeasureValue (MEAN)Dispersion
OMT + BEMER PLACEBONeck Pain Rating Neck Disability Index (NDI)13 units on a scaleStandard Deviation 7.6
Experimental: Bio Electro-Magnetic Regulation (BEMER) TherapyNeck Pain Rating Neck Disability Index (NDI)7.4 units on a scaleStandard Deviation 8.5
OMT (Osteopathic Manipulative Treatment)Neck Pain Rating Neck Disability Index (NDI)12.2 units on a scaleStandard Deviation 10.9
OMT+BEMERNeck Pain Rating Neck Disability Index (NDI)11.2 units on a scaleStandard Deviation 7.6
Primary

Neck Pain Rating Visual Analog Scale (VAS)

Assessed by questionnaire rating, compared with pre-intervention rating Visual Analog Scale (VAS). Score ranges 0-100. Minimum score=0 (no pain), Maximum score=100 (worst pain ever felt). Lower scores is better as it reflect lower pain

Time frame: Within 1 week of completion of 3-week intervention period

ArmMeasureValue (MEAN)Dispersion
OMT + BEMER PLACEBONeck Pain Rating Visual Analog Scale (VAS)15.5 units on a scaleStandard Deviation 13.4
Experimental: Bio Electro-Magnetic Regulation (BEMER) TherapyNeck Pain Rating Visual Analog Scale (VAS)7.1 units on a scaleStandard Deviation 10.8
OMT (Osteopathic Manipulative Treatment)Neck Pain Rating Visual Analog Scale (VAS)16 units on a scaleStandard Deviation 14.2
OMT+BEMERNeck Pain Rating Visual Analog Scale (VAS)11.5 units on a scaleStandard Deviation 8.4
Primary

Quality of Life Rating Short Form 12-item (SF-12) Health Survey

Assessed by questionnaire rating, compared with pre-intervention rating Short form 12-item (SF-12) health survey. Scores range 0%-100%. Score of 0 (minimum) no pain. Score of 100 (maximum) lot of pain. Lower scores is better as it reflect lower pain

Time frame: Within 1 week of completion of 3-week intervention period

ArmMeasureValue (MEAN)Dispersion
OMT + BEMER PLACEBOQuality of Life Rating Short Form 12-item (SF-12) Health Survey47.5 units on a scaleStandard Deviation 11.1
Experimental: Bio Electro-Magnetic Regulation (BEMER) TherapyQuality of Life Rating Short Form 12-item (SF-12) Health Survey45.4 units on a scaleStandard Deviation 9
OMT (Osteopathic Manipulative Treatment)Quality of Life Rating Short Form 12-item (SF-12) Health Survey43.7 units on a scaleStandard Deviation 14.7
OMT+BEMERQuality of Life Rating Short Form 12-item (SF-12) Health Survey45.6 units on a scaleStandard Deviation 13

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026